ReviewThe dosing and monitoring of Vancomycin (cas 1404-90-6): what is the best way forward?

Add time:09/08/2019    Source:sciencedirect.com

ABSTRACTWe have evaluated the literature to review optimal dosing and monitoring of intravenous vancomycin in adults, in response to evolving understanding of targets associated with efficacy and toxicity. The area under the total concentration–time curve (0–24 h) divided by the minimum inhibitory concentration (AUC24/MIC) is the most commonly accepted index to guide vancomycin dosing for the treatment of Staphylococcus aureus infections, with a value of 400 h a widely recommended target for efficacy. Upper limits of AUC24 exposure of around 700 (mg/L).h have been proposed, based on the hypothesis that higher exposures of vancomycin are associated with an unacceptable risk of nephrotoxicity. If AUC24/MIC targets are used, sources of variability in the assessment of both AUC24 and MIC need to be considered. Current consensus guidelines recommend measuring trough vancomycin concentrations during intermittent dosing as a surrogate for the AUC24. Trough concentrations are a misleading surrogate for AUC24 and a poor end-point in themselves. AUC24 estimation using log-linear pharmacokinetic methods based on two plasma concentrations, or Bayesian methods are superior. Alternatively, a single concentration measured during continuous infusion allows simple AUC24 estimation and dose-adjustment. All of these methods have logistical challenges which must be overcome if they are to be adopted successfully.

We also recommend Trading Suppliers and Manufacturers of Vancomycin (cas 1404-90-6). Pls Click Website Link as below: cas 1404-90-6 suppliers

Prev:Short reportVancomycin (cas 1404-90-6) use in surrounding patients during critical illness and risk for persistent colonization with Vancomycin (cas 1404-90-6)-resistant Enterococcus
Next:Review ArticleSelection pressures of Vancomycin (cas 1404-90-6) powder use in spine surgery: a meta-analysis)